INS and polycystic ovary syndrome: The ascertained effectiveness of insulin-sensitizing drugs, such as metformin and thiazolidinediones, in improving ovulatory function and reducing androgen excess in PCOS patients provided additional evidence that supports the pathogenic role of insulin resistance in PCOS [10].